We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -1.03% | 9.65 | 9.30 | 10.00 | 9.75 | 9.65 | 9.75 | 542,863 | 10:14:22 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.48 | 89.53M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/1/2019 08:36 | Tarquinius thank you for posting. What de Leader would give e for 15 supporters. Take away his bogus accounts( useful in a CON mans game and the love children like Ray P and he will only get few recommends. If all his Altar eggs oukd posthe night get 15 recs then guffaw | drdobson1 | |
29/1/2019 08:31 | What does 15 recs tell *US ALL* - The M F F F does NOT have 16 'regular posters' However, The M F F F DOES have a small number of 'regular trHYPERS' The fact that a post from ONE source is 'taken as fact' by Sooo many, is indicative of just how much the posts by der leader 'n' co are NOT, by Sooo many { and rightly so} . Konar's post gives HOPE for those 'Long Term Sufferers' = 15 recs der leader just adds more trHYPE to the BUY,BUY,BUY SCAM = mistrust by the majority, sitting on LOSSES | the real lozan | |
29/1/2019 06:44 | With 15 recs it was the sort of post appreciated by others. The facts were stated and explained simply in his own words. He didn't hang around for applause either. | gazza | |
29/1/2019 00:21 | For those who don't follow LSE, here's Konar's kind explanation 10.22 yesterday about the USA Patent hints earlier :- ''The examiner approved the US patent in principle, but asked for a post approval minor change to a table in the application before he would issue. Scancell submitted that change, just before the US government shutdown, and whilst the USPTO acknowledged receipt, there was no further processing. On the day the US government reopened, they posted an update to our lawyers to say they are now happy with the amend, and that the application is now deemed ready to issue. In other words, dragged on a bit these last couple of months, but US patent is confirmed accepted.'' Thanks to Konar and all. Essential enlightenment ! | torquayfan | |
28/1/2019 19:10 | Evening See the Village Idiott has returned to infest this balanced bulletin board with his Cut and paste CONsense and his RANTS. Total hypocrite in that he dies not want anyone Cluttering up the boards but he repeatedly posts his Bile and lies cluttering up all boards even when hevus not welcome. On MFFF he quotes from the Greek.Well I can do that he is A PARASIte from thecGreek 1530s, "a hanger-on, a toady, person who lives on others," from Middle French parasite (16c.) or directly from Latin parasitus "toady, sponger," and directly from Greek parasitos "one who lives at another's expense, person who eats at the table of another," from noun use of an adjective meaning "feeding beside," from ... Think it gets baNANA the faiked Proffessor PKUM off to a Tee | drdobson1 | |
28/1/2019 11:56 | Gazza Staedy...:-) | oldnotwise | |
28/1/2019 11:37 | I have to be really careful with cut'n'paste as I tend to transpose the t and n. | gazza | |
28/1/2019 10:12 | Gazza Yes, like it.... Cloudburst of cut and paste? (apols to Lozan) ATB | oldnotwise | |
28/1/2019 10:08 | I like the phrases... ONW - "Storm of science" Lozan "tsunami of cut'n'paste" How about "hurricane of hype" | gazza | |
28/1/2019 10:04 | Good old RP trying to keep the masses quiet..... Now they've got to try and work out what's going on hehe... AIMO ATB | oldnotwise | |
28/1/2019 09:46 | Oh, I see the,"isn't Trigrid V2 already approved in other Trials?" bit already started.. hehe ATB | oldnotwise | |
28/1/2019 09:44 | Berm Absolutely, I did read that they had been sent (but maybe that was your post.. :-) Let's hope that's the case and since it was a follow up question/s to the original application I guess that will allow a smooth passage through the FDA (IE fees, and disasters from Gvt Shutdown). Incidentally, I've no reason to suggest there'll be anything but a positve response, my point was the fact that I'm sure there'll be a range war going soon on the other BB as those that think a storm of "science" will batter Gunthorpe into submission, which I'm not sure will be the case. Could be interesting..... (at least a great deal more so than watching every trade that takes place and then attempting to extrapolate the nesxt share price move)..... AIMO ATB | oldnotwise | |
28/1/2019 09:36 | ONW - in the recent Proactive interview with CH I couldn't quite hear whether he said O/S requirements for IND have now BEEN sent to the FDA or were BEING sent. Obviously makes quite a difference to when we can expect news. | bermudashorts | |
28/1/2019 09:32 | Konar, Re. my 19096 - think I am with you now thanks to Scrumpy! I assume you're talking about the US original Moditope patent application. | bermudashorts | |
28/1/2019 09:30 | Gunthorpe looks interesting .... I'm waiting for the (misinformed) comment in reply that Tigrid V2 is already Approved... (which in Scancell's case it is not)! Should be interesting... AIMO ATB | oldnotwise | |
28/1/2019 09:10 | Looks like someone dropped 64K odd at 7.3903p (maybe a bit of a panicky reaction to early price)and with the offer now at 7.625p a bit of anotomical clenching for some I'd say. Wonder if that first trade will stay? Wait and see time ... again. ATB | oldnotwise | |
27/1/2019 23:12 | as we are using Keytruda ... straight of the advert ... PD-1 and PD-L1 are types of proteins found on cells in your body. PD‑1 protein is found on immune cells called T cells. It normally acts as a type of "off switch" that helps keep the T cells from attacking other cells in the body. PD-1 attaches to PD‑L1, a protein found on some normal (and cancer) cells. This interaction basically tells the T cell to leave the other cell alone and not attack it. Some cancer cells have large amounts of PD‑L1, which helps them hide from immune attack. so Lindy has seen the effect in two cancer types in the mouse model how strange to get two out of two to show efficacy .. | inanaco | |
27/1/2019 22:57 | its the mechanism of action that is in discussion .... SCIB1 has proven T cells Keytruda has proven efficacy so which trial don't you believe ? | inanaco | |
27/1/2019 22:52 | Konar, Not sure whether or not you ever look in here but noticed your 18.51 post on lse. Other than the recent UK publication of the 'epitopes' patent (which I assume is homocitrullinated epitopes?), is there any other news that has been missed? | bermudashorts | |
27/1/2019 22:43 | Inanaco - This will be my final reply to you. With respect, you don't get it. You simply can not go around using language like 'proven' when it comes to any new drug unless it has been. | bermudashorts | |
27/1/2019 22:20 | Lozan, spot on, then he has the bare face cheek to accuse people who make one or two pertinent comments of "cluttering up" the bb. It does seem he is trying to drown out anybody else's view with his "dross". | gazza | |
27/1/2019 22:18 | Boom again you still have not got it ... a CD8 t cell is a CD8 t cell ... inovio cd8 t cells are the same t cells as scancells .. the only difference is how they are engaged to produce high avidity which is why any t cell CD8 will react with PD-1 ligand why can't you accept the Trial results of Keytruda and Opdivo .. ? scancell has not had to modify SCIB1 to suit Keytruda ... because Keytruda Modifies the micro environment for T cells """ The use of immune checkpoint inhibitors for the treatment of cancer is revolutionizing oncology. Amongst these therapeutic agents, antibodies that block PD-L1/PD1 interactions between cancer cells and T cells are demonstrating high efficacies and low toxicities """" | inanaco | |
27/1/2019 21:43 | Yep - time to move on. Interims due shortly, should get an update on the IND and hopefully Scancell can start reporting some positive news. | bermudashorts |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions